Multiple Sclerosis Trials

For more information on Multiple Sclerosis Clinical Trials, contact Diane Coman at (615) 222-1232.

Principal Investigator:
Dr. Robert Fallis
St Thomas Neurology Specialists
(615) 222-1258

TRIAL ​STATUS ​DESCRIPTION
ASSESS ​ACTIVELY Recruiting Patients / OPEN Enrollment ​This study compares the efficacy and safety of Fingolimod (Gilenya) 0.25mg and 0.5mg administered orally once a day with Copaxone injections in patients with Relapsing Remitting Multiple Sclerosis.
CONCERTO ​​ACTIVELY Recruiting Patients / OPEN Enrollment ​A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by an active treatment period, to evaluate the efficacy, safety and tolerability of two doses of oral administration of laquinimod (0.6 mg/day or 1.2 mg/day) in subjects with relapsing remitting multiple sclerosis (RRMS)
Stratify 2 ​Follow up status for enrolled participants / NOT open for enrollment ​JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri.
BRAVO ​Follow up status for enrolled participants / NOT open for enrollment ​To compare the effect of an investigational daily oral treatment in comparison with a placebo in subjects with relapsing remitting multiple sclerosis.

Related Links

Our Locations

UNITY - Nurse Navigator
Phone:
(615) 222-STNI (7864)

Saint Thomas Midtown Hospital
2000 Church Street
Nashville, TN 37236
Phone: (615) 284-5555
View Google Map Directions

Saint Thomas West Hospital
4220 Harding Road
Nashville, TN 37205
Phone: (615) 222-2111
View Google Map Directions

Saint Thomas Rutherford Hospital
1700 Medical Center Parkway
Murfreesboro, TN 37130
Phone: (615) 396-4100
View Google Map Directions
Retrieving Data